The Zhitong Finance App learned that on Thursday, the opening of ATAIBeckley Inc. (ATAI.US) soared by more than 30% to a new high during the year, and now reports $7.05. According to the news, LLY.US (LLY.US) has agreed to acquire AtaiBeckley Inc., for up to $3.8 billion, which highlights the growing interest of large pharmaceutical companies in hallucinogenic drugs (psychedelic medicine), which was once a marginal field. According to a statement on Thursday, Eli Lilly will pay $6.75 per share in cash and up to $2.50 per share if drug development milestones are reached. The underlying price was 26% higher than ATaiBeckley's close on Wednesday.

Zhitongcaijing · 1d ago
The Zhitong Finance App learned that on Thursday, the opening of ATAIBeckley Inc. (ATAI.US) soared by more than 30% to a new high during the year, and now reports $7.05. According to the news, LLY.US (LLY.US) has agreed to acquire AtaiBeckley Inc., for up to $3.8 billion, which highlights the growing interest of large pharmaceutical companies in hallucinogenic drugs (psychedelic medicine), which was once a marginal field. According to a statement on Thursday, Eli Lilly will pay $6.75 per share in cash and up to $2.50 per share if drug development milestones are reached. The underlying price was 26% higher than ATaiBeckley's close on Wednesday.